4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001144204-17-051545
Options or other derivatives
- Chief Financial Officer acquired 145,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Foster Jonathan P. · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-10-03 | Grant or award : show line 1 in the form Stock option (right to buy) | +145,000 | 545,000 | D |
Loading xslF345X03/v476493_4.xml…